196 related articles for article (PubMed ID: 32739312)
1. Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia.
Dhakal P; Shostrom V; Al-Kadhimi ZS; Maness LJ; Gundabolu K; Bhatt VR
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):804-812.e8. PubMed ID: 32739312
[TBL] [Abstract][Full Text] [Related]
2. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
3. Survival of Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Effect of Using Multiagent Versus Single-agent Chemotherapy.
Bhatt VR; Shostrom V; Holstein SA; Al-Kadhimi ZS; Maness LJ; Berger A; Armitage JO; Gundabolu K
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):e239-e258. PubMed ID: 32111572
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
Tawfik B; Pardee TS; Isom S; Sliesoraitis S; Winter A; Lawrence J; Powell BL; Klepin HD
J Geriatr Oncol; 2016 Jan; 7(1):24-31. PubMed ID: 26527394
[TBL] [Abstract][Full Text] [Related]
5. Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome.
Chien SH; Yao M; Li CC; Chang PY; Yu MS; Huang CE; Tan TD; Lin CH; Yeh SP; Li SS; Wang PN; Liu YC; Gau JP
J Formos Med Assoc; 2021 Dec; 120(12):2144-2152. PubMed ID: 33423899
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity burden and outcomes of older adults with acute promyelocytic leukemia: a National Cancer Database analysis of 2221 patients.
Dhakal P; Lyden E; Joshi U; Pyakuryal A; Loh KP; Klepin H; Bhatt VR
Leuk Lymphoma; 2023 Mar; 64(3):691-697. PubMed ID: 36629003
[TBL] [Abstract][Full Text] [Related]
7. Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015.
Wang CY; Huang HH; Chen HM; Hsiao FY; Ko BS
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e649-e657. PubMed ID: 33931380
[TBL] [Abstract][Full Text] [Related]
8. Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.
Budziszewska BK; Pluta A; Sulek K; Wierzbowska A; Robak T; Giebel S; Holowiecka-Goral A; Sawicki W; Ejduk A; Patkowska E; Manko J; Gajkowska-Kulik J; Piszcz J; Mordak-Domagala M; Madry K; Holowiecki J; Kyrcz-Krzemien S; Nowakowska-Domagala M; Dmoszynska A; Calbecka M; Kloczko J; Wiktor Jędrzejczak W; Lange A; Razny M; Bilinski P; Warzocha K; Lech-Maranda E
Leuk Lymphoma; 2015; 56(8):2331-8. PubMed ID: 25393675
[TBL] [Abstract][Full Text] [Related]
9. Determinants of ten-year overall survival of acute myeloid leukemia: a large national cancer database analysis.
Khanal N; Shostrom V; Dhakal P; Upadhyay Banskota S; Chaulagain C; He F; Mosalpuria K; Gundabolu K; Bhatt VR
Leuk Lymphoma; 2022 Apr; 63(4):939-945. PubMed ID: 34789057
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015.
Chien LN; Tzeng HE; Liu HY; Chou WC; Tien HF; Hou HA
J Formos Med Assoc; 2023 Jun; 122(6):505-513. PubMed ID: 36369106
[TBL] [Abstract][Full Text] [Related]
12. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of older adults with acute myeloid Leukemia: An analysis of a large tertiary referral Center over two decades.
Ihlow J; Gross S; Neuendorff NR; Busack L; Herneth A; Singh A; Schwarz M; Flörcken A; Anagnostopoulos I; Türkmen S; Burmeister T; Blau IW; Bullinger L; Westermann J
J Geriatr Oncol; 2021 May; 12(4):540-549. PubMed ID: 33223482
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality.
Master S; Mansour R; Devarakonda SS; Shi Z; Mills G; Shi R
Anticancer Res; 2016 Apr; 36(4):1719-27. PubMed ID: 27069151
[TBL] [Abstract][Full Text] [Related]
15. Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study.
Reagan JL; Sullivan MR; Winer ES; Lansigan F; Cardin MS; Castillo JJ
Leuk Res; 2015 Aug; 39(8):812-7. PubMed ID: 26045177
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
Dharmani C; Wang E; Tu N; Salas M; Kamel YM
Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and survival predictors of Latin American older adults with acute myeloid leukemia: Data from a single center.
Jaime-Pérez JC; Ramos-Dávila EM; Picón-Galindo E; Jiménez-Castillo RA; León AG; Gómez-Almaguer D
Hematol Transfus Cell Ther; 2023 Jul; 45 Suppl 2(Suppl 2):S43-S50. PubMed ID: 35115270
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
Breccia M; Frustaci AM; Cannella L; Stefanizzi C; Latagliata R; Cartoni C; Diverio D; Guarini A; Nanni M; Rago A; Cimino G; Alimena G
Hematol Oncol; 2009 Sep; 27(3):148-53. PubMed ID: 19274612
[TBL] [Abstract][Full Text] [Related]
19. Early mortality and overall survival of acute myeloid leukemia based on facility type.
Bhatt VR; Shostrom V; Giri S; Gundabolu K; Monirul Islam KM; Appelbaum FR; Maness LJ
Am J Hematol; 2017 Aug; 92(8):764-771. PubMed ID: 28437868
[TBL] [Abstract][Full Text] [Related]
20. Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia.
Kuhlman P; Isom S; Pardee TS; Burns C; Tawfik B; Lamar ZS; Powell BL; Klepin HD
Support Care Cancer; 2019 Aug; 27(8):2877-2884. PubMed ID: 30554278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
